Connection

Alicia Jenkins to Diabetes Mellitus, Type 1

Back to Details
This is a "connection" page, showing publications Alicia Jenkins has written about Diabetes Mellitus, Type 1.
Alicia Jenkins
Connection Strength
13.425
Diabetes Mellitus, Type 1
  1. Independent euglycaemic hyperinsulinaemic clamp studies validate clinically applicable formulae to estimate insulin sensitivity in people with type 1 diabetes. Diabetes Metab Syndr. 2023 Jan; 17(1):102691.
    View in: PubMed
    Score: 0.610
  2. Insulin antibodies are prevalent in adults with type 1 diabetes referred for islet cell transplantation and are modified by islet transplantation and immunosuppression: an Australian experience. Intern Med J. 2022 08; 52(8):1434-1436.
    View in: PubMed
    Score: 0.596
  3. Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes. Sci Rep. 2021 08 17; 11(1):16656.
    View in: PubMed
    Score: 0.558
  4. Serum urate and cardiovascular events in the DCCT/EDIC study. Sci Rep. 2021 07 09; 11(1):14182.
    View in: PubMed
    Score: 0.554
  5. Insulin micro-secretion in Type 1 diabetes and related microRNA profiles. Sci Rep. 2021 06 03; 11(1):11727.
    View in: PubMed
    Score: 0.550
  6. Estimated insulin sensitivity in Type 1 diabetes adults using clinical and research biomarkers. Diabetes Res Clin Pract. 2020 Sep; 167:108359.
    View in: PubMed
    Score: 0.519
  7. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment. BMJ Open. 2019 12 29; 9(12):e033059.
    View in: PubMed
    Score: 0.498
  8. Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common. Intern Med J. 2018 09; 48(9):1080-1086.
    View in: PubMed
    Score: 0.454
  9. Shorter telomeres in adults with Type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors. Diabetes Res Clin Pract. 2016 Jul; 117:4-11.
    View in: PubMed
    Score: 0.386
  10. Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. J Diabetes Complications. 2013 Sep-Oct; 27(5):447-53.
    View in: PubMed
    Score: 0.318
  11. Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Res Clin Pract. 2012 Jan; 95(1):e17-9.
    View in: PubMed
    Score: 0.282
  12. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life. Diabetes Technol Ther. 2011 Feb; 13(2):105-9.
    View in: PubMed
    Score: 0.269
  13. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial. Diabetes Care. 2010 Jun; 33(6):1242-8.
    View in: PubMed
    Score: 0.252
  14. Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus. Diabetes Res Clin Pract. 2008 Aug; 81(2):e8-10.
    View in: PubMed
    Score: 0.223
  15. Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort. J Diabetes Complications. 2008 May-Jun; 22(3):153-63.
    View in: PubMed
    Score: 0.221
  16. Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus. J Med Invest. 2008 Feb; 55(1-2):29-36.
    View in: PubMed
    Score: 0.218
  17. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease. Clin Sci (Lond). 2005 Jun; 108(6):497-506.
    View in: PubMed
    Score: 0.181
  18. 'Lipoproteins, glycoxidation and diabetic angiopathy'. Diabetes Metab Res Rev. 2004 Sep-Oct; 20(5):349-68.
    View in: PubMed
    Score: 0.172
  19. In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes. Metabolism. 2004 Aug; 53(8):969-76.
    View in: PubMed
    Score: 0.171
  20. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care. 2003 Mar; 26(3):810-8.
    View in: PubMed
    Score: 0.155
  21. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes. Diabetes Technol Ther. 2023 02; 25(2):108-115.
    View in: PubMed
    Score: 0.153
  22. Late Afternoon Vigorous Exercise Increases Postmeal but Not Overnight Hypoglycemia in Adults with Type 1 Diabetes Managed with Automated Insulin Delivery. Diabetes Technol Ther. 2022 Dec; 24(12):873-880.
    View in: PubMed
    Score: 0.152
  23. Optimal Frequency of Retinopathy Screening in Adolescents With Type 1 Diabetes: Markov Modeling Approach Based on 30 Years of Data. Diabetes Care. 2022 10 01; 45(10):2383-2390.
    View in: PubMed
    Score: 0.151
  24. Upload and Review of Insulin Pump and Glucose Sensor Data by Adults with Type 1 Diabetes: A Clinic Audit. Diabetes Technol Ther. 2022 07; 24(7):531-534.
    View in: PubMed
    Score: 0.147
  25. Telomeres do not always shorten over time in individuals with type 1 diabetes. Diabetes Res Clin Pract. 2022 Jun; 188:109926.
    View in: PubMed
    Score: 0.147
  26. Multifocal pupillographic objective perimetry for assessment of early diabetic retinopathy and generalised diabetes-related tissue injury in persons with type 1 diabetes. BMC Ophthalmol. 2022 Apr 13; 22(1):166.
    View in: PubMed
    Score: 0.146
  27. A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes. Diabetes Care. 2022 01 01; 45(1):194-203.
    View in: PubMed
    Score: 0.143
  28. Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision. Diabetes Res Clin Pract. 2021 Sep; 179:109000.
    View in: PubMed
    Score: 0.140
  29. Baseline extended zone retinal vascular calibres associate with sensory nerve abnormalities in adolescents with type 1 diabetes: A prospective longitudinal study. Diabet Med. 2021 11; 38(11):e14662.
    View in: PubMed
    Score: 0.139
  30. Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: The REMOVAL trial. Diabetes Obes Metab. 2021 06; 23(6):1371-1378.
    View in: PubMed
    Score: 0.135
  31. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections. Diabetes Technol Ther. 2021 06; 23(6):460-466.
    View in: PubMed
    Score: 0.134
  32. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial. Diabetes Care. 2020 12; 43(12):3024-3033.
    View in: PubMed
    Score: 0.132
  33. Vitamin D Metabolites and Binding Protein Predict Preeclampsia in Women with Type 1 Diabetes. Nutrients. 2020 Jul 10; 12(7).
    View in: PubMed
    Score: 0.129
  34. Extended-Zone Retinal Vascular Caliber and Risk of Diabetic Retinopathy in Adolescents with Type 1 Diabetes. Ophthalmol Retina. 2020 12; 4(12):1151-1157.
    View in: PubMed
    Score: 0.128
  35. Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study. Diabetes Care. 2020 02; 43(2):480-483.
    View in: PubMed
    Score: 0.124
  36. Associations between circulating inflammatory markers, diabetes type and complications in youth. Pediatr Diabetes. 2019 12; 20(8):1118-1127.
    View in: PubMed
    Score: 0.122
  37. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 10 01; 104(10):4743-4755.
    View in: PubMed
    Score: 0.122
  38. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study. Diabetes Technol Ther. 2019 09; 21(9):499-506.
    View in: PubMed
    Score: 0.120
  39. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D. J Lipid Res. 2019 08; 60(8):1432-1439.
    View in: PubMed
    Score: 0.120
  40. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study. Diabetes Technol Ther. 2019 01; 21(1):56-58.
    View in: PubMed
    Score: 0.116
  41. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol. BMJ Open. 2018 06 09; 8(6):e020274.
    View in: PubMed
    Score: 0.112
  42. Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D. J Lipid Res. 2018 05; 59(5):872-883.
    View in: PubMed
    Score: 0.110
  43. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care. 2018 01; 41(1):120-127.
    View in: PubMed
    Score: 0.107
  44. Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes. Diabetologia. 2017 12; 60(12):2514-2524.
    View in: PubMed
    Score: 0.106
  45. Incidence and Mortality Rates and Clinical Characteristics of Type 1 Diabetes among Children and Young Adults in Cochabamba, Bolivia. J Diabetes Res. 2017; 2017:8454757.
    View in: PubMed
    Score: 0.106
  46. Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes. Diabetologia. 2017 10; 60(10):2103-2110.
    View in: PubMed
    Score: 0.105
  47. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017 08; 5(8):597-609.
    View in: PubMed
    Score: 0.104
  48. Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study. Diabetes Technol Ther. 2017 06; 19(6):340-348.
    View in: PubMed
    Score: 0.104
  49. Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend. Diabetes Technol Ther. 2017 07; 19(7):438-439.
    View in: PubMed
    Score: 0.104
  50. "It Is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes. Diabetes Technol Ther. 2017 07; 19(7):410-416.
    View in: PubMed
    Score: 0.104
  51. Progressive Retinal Vasodilation in Patients With Type 1 Diabetes: A Longitudinal Study of Retinal Vascular Geometry. Invest Ophthalmol Vis Sci. 2017 05 01; 58(5):2503-2509.
    View in: PubMed
    Score: 0.104
  52. Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial. Diabetes Obes Metab. 2017 04; 19(4):509-516.
    View in: PubMed
    Score: 0.102
  53. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study. Diabetes Technol Ther. 2016 12; 18(12):772-783.
    View in: PubMed
    Score: 0.100
  54. Retinal neuronal and vascular function in type 1 diabetes adults during glycaemic clamps. Clin Exp Pharmacol Physiol. 2016 Mar; 43(3):382-4.
    View in: PubMed
    Score: 0.095
  55. Circulating microRNA Biomarkers of Diabetic Retinopathy. Diabetes. 2016 Jan; 65(1):22-4.
    View in: PubMed
    Score: 0.094
  56. Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes. J Lipid Res. 2016 Feb; 57(2):310-7.
    View in: PubMed
    Score: 0.094
  57. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis. 2016 Jan; 244:93-100.
    View in: PubMed
    Score: 0.093
  58. Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutr Res. 2015 May; 35(5):421-30.
    View in: PubMed
    Score: 0.090
  59. Sex differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications? Invest Ophthalmol Vis Sci. 2014 Dec 04; 56(1):571-7.
    View in: PubMed
    Score: 0.088
  60. Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study. Atherosclerosis. 2014 Sep; 236(1):188-195.
    View in: PubMed
    Score: 0.085
  61. Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care. 2013 Jul; 36(7):2054-61.
    View in: PubMed
    Score: 0.077
  62. Normalized NEFA dynamics during an OGTT after islet transplantation. Transplantation. 2012 Oct 15; 94(7):e49-51.
    View in: PubMed
    Score: 0.076
  63. Therapeutic effects of PPARa agonists on diabetic retinopathy in type 1 diabetes models. Diabetes. 2013 Jan; 62(1):261-72.
    View in: PubMed
    Score: 0.075
  64. Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes. Diabetes. 2012 Jul; 61(7):1785-92.
    View in: PubMed
    Score: 0.073
  65. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care. 2012 Jun; 35(6):1333-40.
    View in: PubMed
    Score: 0.073
  66. Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. J Clin Endocrinol Metab. 2012 May; 97(5):1752-62.
    View in: PubMed
    Score: 0.073
  67. Plantar fascia thickness is longitudinally associated with retinopathy and renal dysfunction: a prospective study from adolescence to adulthood. J Diabetes Sci Technol. 2012 Mar 01; 6(2):348-55.
    View in: PubMed
    Score: 0.072
  68. Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care. 2012 Mar; 35(3):599-604.
    View in: PubMed
    Score: 0.072
  69. Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes. Am J Ophthalmol. 2012 Jan; 153(1):176-83.e1.
    View in: PubMed
    Score: 0.070
  70. Retinal vascular geometry predicts incident retinopathy in young people with type 1 diabetes: a prospective cohort study from adolescence. Diabetes Care. 2011 Jul; 34(7):1622-7.
    View in: PubMed
    Score: 0.069
  71. Serum carotenoids and fat-soluble vitamins in women with type 1 diabetes and preeclampsia: a longitudinal study. Diabetes Care. 2011 Jun; 34(6):1258-64.
    View in: PubMed
    Score: 0.068
  72. LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses. J Diabetes Complications. 2011 Mar-Apr; 25(2):73-82.
    View in: PubMed
    Score: 0.064
  73. Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes. Diabetes Care. 2009 Nov; 32(11):2081-3.
    View in: PubMed
    Score: 0.061
  74. Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care. 2009 Jan; 32(1):106-10.
    View in: PubMed
    Score: 0.057
  75. Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care. 2008 Sep; 31(9):1842-6.
    View in: PubMed
    Score: 0.056
  76. Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes. Diabetes Care. 2008 Aug; 31(8):1585-9.
    View in: PubMed
    Score: 0.056
  77. Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J Lipid Res. 2008 Apr; 49(4):847-55.
    View in: PubMed
    Score: 0.054
  78. Association between PON 1 polymorphisms, PON activity and diabetes complications. J Diabetes Complications. 2006 Sep-Oct; 20(5):322-8.
    View in: PubMed
    Score: 0.049
  79. Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology. 2006 Sep; 113(9):1499-503.
    View in: PubMed
    Score: 0.049
  80. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis. 2007 Feb; 190(2):359-69.
    View in: PubMed
    Score: 0.048
  81. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation. 2005 May 17; 111(19):2446-53.
    View in: PubMed
    Score: 0.045
  82. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort. J Diabetes Complications. 2005 Jan-Feb; 19(1):18-25.
    View in: PubMed
    Score: 0.044
  83. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses. Metabolism. 2004 Oct; 53(10):1296-304.
    View in: PubMed
    Score: 0.043
  84. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care. 2003 May; 26(5):1439-48.
    View in: PubMed
    Score: 0.039
  85. Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127. Diabetes Care. 2018 06; 41(6):e102-e103.
    View in: PubMed
    Score: 0.028
  86. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care. 2008 Oct; 31(10):2006-12.
    View in: PubMed
    Score: 0.014
  87. Chemical modification of proteins during peroxidation of phospholipids. J Lipid Res. 2005 Jul; 46(7):1440-9.
    View in: PubMed
    Score: 0.011
  88. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci. 2004 Mar; 45(3):910-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.